SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Johannes Martin Schmid, Peter Adler Würtzen, Ronald Dahl, Hans Jürgen Hoffmann, Early improvement in basophil sensitivity predicts symptom relief with grass pollen immunotherapy, Journal of Allergy and Clinical Immunology, 2014,

    CrossRef

  2. 2
    Jörg Kleine-Tebbe, Mikkel Walmar, Klaus Bitsch-Jensen, Elke Decot, Oliver Pfaar, Dolores Hernández Fernández de Rojas, Fernando Rodriguez, Negative Clinical Results from a Randomised, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy of Two Doses of Immunologically Enhanced, Grass Subcutaneous Immunotherapy Despite Dose-Dependent Immunological Response, Clinical Drug Investigation, 2014,

    CrossRef

  3. 3
    Désirée Larenas-Linnemann, Oliver Pfaar, Patient-reported outcomes and quality-of-life questionnaires in the assessment of rhinoconjunctivitis in childhood, Current Opinion in Allergy and Clinical Immunology, 2014, 1

    CrossRef

  4. 4
    Giovanni Passalacqua, Giorgio Canonica, Allergens and Allergen Immunotherapy, 2014,

    CrossRef

  5. 5
    Dimitris I Mitsias, Lampros A Kalogiros, Nikolaos G Papadopoulos, Conference Scene: Novelties in immunotherapy, Immunotherapy, 2013, 5, 10, 1033

    CrossRef

  6. 6
    Jan-Alexander Schwab, Hendrik Wolf, Jörg Schnitker, Eike Wüstenberg, Safety and Tolerability of an Intra-seasonal Initiation of the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-interventional Observational Study Investigating the Feasibility During Routine Administration, Clinical Drug Investigation, 2013, 33, 10, 719

    CrossRef

  7. 7
    Giovanni Passalacqua, Valentina Garelli, Francesca Sclifò, Giorgio Walter Canonica, Sublingual immunotherapy for allergic rhinitis and conjunctivitis, Immunotherapy, 2013, 5, 3, 257

    CrossRef

  8. 8
    Antonio Cappella, Stephen R. Durham, Allergen immunotherapy for allergic respiratory diseases, Human vaccines & immunotherapeutics, 2012, 8, 10, 1499

    CrossRef

  9. 9
    I. Stelmach, I. Kaluzińska-Parzyszek, J. Jerzynska, P. Stelmach, W. Stelmach, P. Majak, Comparative effect of pre-coseasonal and continuous grass sublingual immunotherapy in children, Allergy, 2012, 67, 3
  10. 10
    R. L. Clancy, Towards a vaccine for chronic obstructive pulmonary disease, Internal Medicine Journal, 2012, 42, 6
  11. 11
    Gian Enrico Senna, Moises Calderon, Massimo Milani, Allergy immunotherapy tablet: Grazax®for the treatment of grass pollen allergy, Expert Review of Clinical Immunology, 2011, 7, 1, 21

    CrossRef

  12. You have full text access to this OnlineOpen article12
    M. T. Krishna, A. P. Huissoon, Clinical immunology review series: an approach to desensitization, Clinical & Experimental Immunology, 2011, 163, 2
  13. 13
    Giovanni B. Pajno, Lucia Caminiti, Giuseppe Crisafulli, Daniela Vita, Mariella Valenzise, Raffaele De Luca, Giovanni Passalacqua, Direct comparison between continuous and coseasonal regimen for sublingual immunotherapy in children with grass allergy: A randomized controlled study, Pediatric Allergy and Immunology, 2011, 22, 8
  14. 14
    J. Bousquet, H. J. Schünemann, P. J. Bousquet, C. Bachert, G. W. Canonica, T. B. Casale, P. Demoly, S. Durham, K.-H. Carlsen, H.-J. Malling, G. Passalacqua, F. E. R. Simons, J. Anto, C. E. Baena-Cagnani, K.-C. Bergmann, T. Bieber, A. H. Briggs, J. Brozek, M. A. Calderon, R. Dahl, P. Devillier, R. Gerth van Wijk, P. Howarth, D. Larenas, N. G. Papadopoulos, P. Schmid-Grendelmeier, T. Zuberbier, How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA2LEN statement, Allergy, 2011, 66, 6
  15. 15
    Kristian Reich, Christian Gessner, Axel Kroker, Jan Alexander Schwab, Wolfgang Pohl, Hanne Villesen, Eike Wüstenberg, Waltraud Emminger, Immunologic Effects and Tolerability Profile of In-Season Initiation of a Standardized-Quality Grass Allergy Immunotherapy Tablet: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial in Adults with Grass Pollen–Induced Rhinoconjunctivitis, Clinical Therapeutics, 2011, 33, 7, 828

    CrossRef

  16. You have free access to this content16
    S. M. Walker, S. R. Durham, S. J. Till, G. Roberts, C. J. Corrigan, S. C. Leech, M. T. Krishna, R. K. Rajakulasingham, A. Williams, J. Chantrell, L. Dixon, A. J. Frew, S. M. Nasser, Immunotherapy for allergic rhinitis, Clinical & Experimental Allergy, 2011, 41, 9
  17. 17
    M. H. Shamji, S. R. Durham, Mechanisms of immunotherapy to aeroallergens, Clinical & Experimental Allergy, 2011, 41, 9
  18. 18
    Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua, New approaches to the design of sublingual immunotherapy clinical trials, Clinical Investigation, 2011, 1, 6, 805

    CrossRef

  19. 19
    Giovanni Passalacqua, Giorgio Walter Canonica, Sublingual Immunotherapy for Allergic Respiratory Diseases: Efficacy and Safety, Immunology and Allergy Clinics of North America, 2011, 31, 2, 265

    CrossRef

  20. 20
    Takashi Fujimura, Yoshitaka Okamoto, Antigen-Specific Immunotherapy against Allergic Rhinitis: The State of the Art, Allergology International, 2010, 59, 1, 21

    CrossRef

  21. 21
    C. Lombardi, C. Incorvaia, M. Braga, G. Senna, G. W. Canonica, G. Passalacqua, Administration regimens for sublingual immunotherapy to pollen allergens: What do we know?, Allergy, 2009, 64, 6
  22. 22
    Anaïs Pipet, Karine Botturi, Domitille Pinot, Daniel Vervloet, Antoine Magnan, Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy, Respiratory Medicine, 2009, 103, 6, 800

    CrossRef

  23. 23
    &NA;, CHAPTER 11: METHODOLOGY OF CLINICAL TRIALS IN SUBLINGUAL IMMUNOTHERAPY, World Allergy Organization Journal, 2009, 2, 11, 274

    CrossRef

  24. 24
    Thomas B. Casale, G. Walter Canonica, Jean Bousquet, Linda Cox, Richard Lockey, Harold S. Nelson, Giovanni Passalacqua, Recommendations for appropriate sublingual immunotherapy clinical trials, Journal of Allergy and Clinical Immunology, 2009, 124, 4, 665

    CrossRef

  25. 25
    Désirée Larenas-Linnemann, Sublingual immunotherapy in children: complete and updated review supporting evidence of effect, Current Opinion in Allergy and Clinical Immunology, 2009, 9, 2, 168

    CrossRef

  26. 26
    Désirée Larenas-Linnemann, Sublingual immunotherapy in children: more optimism today, Pediatric Allergy and Immunology, 2009, 20, 4
  27. 27
    Giovanni Passalacqua, Ruby Pawankar, Carlos E Baena-Cagnani, Giorgio Walter Canonica, Sublingual immunotherapy: where do we stand? Present and future, Current Opinion in Allergy and Clinical Immunology, 2009, 9, 1, 1

    CrossRef

  28. 28
    J W Wells, K Choy, C M Lloyd, A Noble, Suppression of allergic airway inflammation and IgE responses by a class I restricted allergen peptide vaccine, Mucosal Immunology, 2009, 2, 1, 54

    CrossRef

  29. 29
    C. Ponvert, Quoi de neuf en allergologie pédiatrique en 2006–2007 ? Partie 2 : allergie oculaire et respiratoire. (Une revue de la littérature internationale d’octobre 2005 à septembre 2007), Revue Française d'Allergologie et d'Immunologie Clinique, 2008, 48, 1, 35

    CrossRef

  30. 30
    Désirée Larenas-Linnemann, Subcutaneous and sublingual immunotherapy in children: Complete update on controversies, dosing, and efficacy, Current Allergy and Asthma Reports, 2008, 8, 6, 465

    CrossRef

  31. 31
    Roy Gerth van Wijk, Sublingual immunotherapy in children, Expert Opinion on Biological Therapy, 2008, 8, 3, 291

    CrossRef

  32. 32
    Stephen R Durham, Sublingual immunotherapy: what have we learnt from the ‘big trials’?, Current Opinion in Allergy and Clinical Immunology, 2008, 8, 6, 577

    CrossRef

  33. 33
    Roy Gerth van Wijk, When to initiate immunotherapy in children with allergic disease? Lessons from the paediatric studies, Current Opinion in Allergy and Clinical Immunology, 2008, 8, 6, 565

    CrossRef

  34. 34
    Philippe Jean Bousquet, Pascal Demoly, Giovanni Passalacqua, G Walter Canonica, Jean Bousquet, Immunotherapy: clinical trials – optimal trial and clinical outcomes, Current Opinion in Allergy and Clinical Immunology, 2007, 7, 6, 561

    CrossRef